Medical Use – IMI Site Thu, 16 Dec 2021 07:08:55 +0000 en-US hourly 1 Medical Use – IMI Site 32 32 Psychedelics rejected for therapeutic purposes in Australia Thu, 16 Dec 2021 01:48:00 +0000

Psychedelic researchers have backed the medical regulator’s decision. Photo by James MacDonald / Bloomberg via Getty Images

Psychedelic drugs will not be legalized for therapeutic purposes in Australia, the country’s medical regulator has said.

The Therapeutic Goods Administration (TGA) on Wednesday rejected a request to change Australia’s poison standard and reduce drugs like psilocybin and MDMA from schedule 9 – banned substances – to schedule 8 – controlled substances.

The ruling means the drugs cannot be used in psychotherapeutic treatment for mental illness, depression and post-traumatic stress disorder, even with permission from an attending psychiatrist or doctor addiction specialist in a medically controlled environment.

In one declaration, the TGA said its decision was based on concerns that legalizing the use of the substances in therapeutic settings could lead to misuse or abuse in non-clinical settings.

“The benefit is very limited because studies with psilocybin only indicate potential therapeutic value in circumstances where the treatment has been provided to subjects in a clinical trial,” said the decision maker. final.

“Regarding the risks, I am convinced that psilocybin presents a high danger for both acute and long-term effects if misused or misused by access outside strictly controlled medical and scientific research parameters. . ”

“In view of this increased risk to individuals of both acute and long-term effects, a high level of control throughout the supply chain in accordance with Annex 9 is warranted.”

The author further noted that most submissions supporting the downscaling of psilocybin and MDMA came from people who were consumers or patients with a personal interest in how the drugs were scheduled, as well as experts who had previously provided comments on the matter.

The Royal Australian and New Zealand College of Psychiatrists (RANZCP) has not supported the proposal to reprogram the drugs, according to the TGA statement, while the Australian Medical Association (AMA) has reportedly suggested that more high-quality research using larger scale studies need to be completed to determine the safety and effectiveness of psilocybin or MDMA use for mental illness.

While the TGA’s ruling is an effective reinforcement of the status quo, it lags a growing number of jurisdictions in other parts of the world. Last November, Oregon became the first state in the United States legalize psilocybin for the treatment of mental health in supervised settings, while Canada has started allowing people with depression to legally use the psychedelic. Researchers in the United States are also currently conducting a second Phase 3 trial of the effectiveness of MDMA-assisted therapy, and if successful, the Food and Drug Administration (FDA) may approve the substance for use. therapies by 2023.

Dr Martin Williams, chief executive of Psychedelic Research in Science and Medicine (PRISM), said he agreed with the TGA’s decision not to reschedule any of the drugs in Australia.

“Although excellent late-phase clinical research is underway worldwide and the results so far have been very promising, we agree that the standards of evidence required for formal approval and implementation have yet to be completed. be respected, “Williams said in a statement. emailed to VICE. “Our strong support for the eventual reprogramming of psilocybin and MDMA…

“Meanwhile, Australian research needs to be done to ensure successful implementation in the local environment, to engage our medical community and to pave the way for proper training and accreditation of Australian mental health professionals in this revolutionary area of ​​mental health practice. “

Dr Stephen Bright, founding member and director of PRISM, also highlighted concerns that rescheduling could “open the door to dangerous and unethical practices”.

“It was no surprise to me,” he told VICE. “Australia was never going to be the first country in the world to manufacture these drugs. [do that]. “

Follow Gavin Butler on Twitter.

Source link

Robert J. Dole Veterans Medical Center Unveils First Robot-Assisted Surgery Tue, 14 Dec 2021 03:40:16 +0000

WICHITA, Kan. (KSNW) – The Robert J. Dole Veterans Medical Center unveiled its first robotic assistant for surgeries on Monday morning.

Robot-assisted surgeries allow medical staff to provide veterans with safer procedures, shorter hospital stays, less post-operative pain, and reduced use of pain relievers, all while reducing the rate of complications.

One of the surgeries performed with the robotic assistant is laparoscopic surgery.

According to Don Vasquez, the general surgeon at VA Medical Center, laparoscopic surgery is surgery that is done through small incisions. The robotic assistant will advance this type of surgery as well as several previously unavailable improvements, such as accuracy and visualization. In addition, the surgeon controls the camera at all times.

Vasquez says the surgery is constantly improving. As for the robotic assistant, it does nothing on its own. It is still laparoscopic surgery, but it increases actions and visualization.

“It allows a surgeon to do some things that are just a little harder to do with the standard laparoscopic approach,” Vasquez said.

According to Vasquez, almost everything done laparoscopically these days is tried robotic. However, not all surgical cases can be performed robotically; some still need to be done with open surgery. Patients may also lack qualification, but this is a discussion to be had between the patient and their surgeon.

Specific training is required in the use of the robotic assistant and supervision when the time comes to use the machine for surgery.

Vasquez demonstrated the use of the robotic assistant for KSN.

Source link

UTEP to develop new initiative to reduce HIV among people who use drugs at the El Paso-Ciudad Juárez border Sun, 12 Dec 2021 00:23:00 +0000

University of Texas at El Paso to develop sustainable public health intervention to suppress human immunodeficiency virus (HIV) in people who use drugs in the El Paso-Ciudad Juárez border region to slow the spread of HIV. The initiative will be funded by a $ 3 million grant from the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA).

Julia Lechuga, Ph.D., associate professor of public health sciences at UTEP, received funding to implement a biobehavioural intervention aimed at suppressing the viral load of HIV in people who inject drugs in order to reduce the likelihood of HIV transmission. The recently funded study is the next phase of Project Encuentro, a community-based HIV risk reduction program in El Paso and Juárez, Mexico, which Lechuga implemented with support from another NIH grant it received in 2016. The Encuentro project is a collaboration between UTEP and Programa Compañeros, a social service organization based in Juárez.

Despite advances in HIV treatment, people are still at risk of contracting and transmitting the virus, especially people who inject drugs. Our goal is to reduce the spread of HIV in our binational community by providing people who use drugs with access to much-needed resources to help them improve their health and quality of life. “

Julia Lechuga, Ph.D., Associate Professor of Public Health Sciences at UTEP

According to the Centers for Disease Control and Prevention, adults and adolescents who inject drugs accounted for 10% of the 37,968 new HIV diagnoses in the United States, the U.S. Territories, and the Republic of Palau in 2018.

The researchers, including professors at the University of California, San Francisco, will use a new phased optimization strategy to develop an intervention to improve antiretroviral treatment adherence in 384 HIV-positive people who use drugs in Juárez.

If taken exactly as prescribed, antiretroviral therapy can reduce the amount of virus, or viral load, in the blood to undetectable levels.

Over the next five years, Lechuga will test four interventions to determine which combinations are most effective in helping people who inject drugs and who are HIV-positive to suppress their viral loads. Strategies include using patient navigators to help participants obtain HIV treatment services, providing psychological therapy to treat depression, improving access to methadone treatment, and providing educational and skills sessions for medication adherence.

Maria Elena Ramos, Executive Director of Programa Compañeros, said the new project will enable the organization to implement new interventions to help people who inject drugs and who are living with HIV to adhere to medication by providing new public health strategies such as psychological therapies.

“This new study will allow us to adapt evidence-based practices and incorporate them into other effective treatment models,” Ramos said. “We will also discover other tools to detect and treat the most prevalent mental health problems such as depression in the population we serve.”

The first NIH grant Lechuga received to fund the Encuentro Project ended earlier this year. Over the past five years, the Encuentro project has directly affected 3,500 people on both sides of the US-Mexico border. The program provided HIV testing to people who injected heroin or crack and offered peer network interventions and educational sessions to reduce the risk of HIV among people who use drugs.

Source link

Global Study Report on Single-Use Medical Device Reprocessing Market 2021-2028 | Stryker Corporation, Medline ReNewal, Centurion Medical Products Corporation Fri, 10 Dec 2021 06:42:49 +0000

The concept of sterilizing, packaging, testing and producing a used product is known as single use medical device reprocessing. The term single-use device does not have a specific definition and depends only on the perception of the end user. Reprocessing of the single-use device is permitted if the device is properly disinfected while retaining its technological and physical functionality. There are two methods of reprocessing single-use medical devices: inpatient treatment and third party treatment. Third-party processing is considered a superior alternative, as regulators may apply strict standards for quality assurance and validation.

Request a FREE PDF brochure with the latest information here @

Reprocessing of single-use medical devices is gaining popularity as a way to minimize hospital waste and save money. For example, Kaiser Permanente, an integrated distribution network based in the United States, saved $ 11 million per year by recycling single-use devices. Reprocessing allows hospitals to get the same device at a lower price than the original device, saving money. According to Practice Green Health, an NGO that provides environmental solutions to the healthcare sector, reprocessing of single-use medical devices prevented the entry of 10,000 tonnes of medical waste between 1997 and 2007, processing around 50 million devices. As hospitals recognize significant cost savings and the possibility of eliminating environmental hazards, the global single use medical device reprocessing market is expected to expand significantly during the forecast period.

Hospital cost restraints and beneficial environmental impact are expected to fuel the global single-use medical device reprocessing market during the forecast period.

𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞 !!!!!!!
𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Buy this premium report with a reduced rate @

Hospitals around the world are facing financial hardship as the cost of original medical devices increases. With the change of government in the United States, Obamacare and the standards that accompany it could be repealed. This could result in low reimbursement by third parties for hospitals, prompting them to implement cost-cutting measures such as reprocessing of single-use medical devices. The most important benefit is that hospitals can reduce medical device costs by around 50%, which is essential when it comes to expensive devices such as catheters and cardiac ablation devices. Currently, 250 medical devices are being processed, 10% of medical devices being suitable for reprocessing single-use medical devices. In terms of environmental protection, hospitals can reduce medical waste by up to 50% by using the reprocessing of single-use medical devices. Healthcare waste management not only puts tremendous pressure on hospital costs, but it has also become a market in its own right in countries like Japan, the United States, and China. For example, Ascent, a subsidiary of Stryker Corporation, was able to divert 1,684 tonnes of medical landfill waste in 2007 through reprocessing. Due to the environmental sustainability and significant cost savings associated with reprocessing, small and medium sized hospitals are ready to improve their presence in the market for the reprocessing of single use medical devices.

North America Expected to Account for Largest Share of Global Single-Use Medical Device Reprocessing Market

The United States has the largest healthcare system in the world, with government spending an average of 30% of its annual budget for healthcare. Major hospitals in the United States include Beth Israel Deaconess Medical Center, Cleveland Clinic, Johns Hopkins Hospital, and Mount Sinai Hospital. In the aftermath of the recession, these hospitals need to meet sustainability goals while controlling spending. For example, 45% of US hospitals signed agreements with third-party processing companies in 2007, and this figure rose to 70% in 2008 due to the severe economic recession. The United States Food and Drug Administration regulates the reprocessing of single-use medical devices and requires third-party processors to maintain quality requirements in accordance with the original devices. The United States Food and Drug Administration has developed strict regulations to ensure consistency and eliminate illnesses associated with the reuse of single-use devices. The United States Food and Drug Administration has a complaints system in place to report adverse events associated with the use of single-use devices, which in turn supports accountability.

Lack of regulatory requirements in places such as Asia-Pacific, Europe, and South America is a restraining factor driving the growth of the global single-use medical device reprocessing market over the course of the period. forecast period. The European Union has not established any reprocessing guidelines. Some European countries like France, Spain and England are opposed to reprocessing. In Asia-Pacific, the reuse of single-use medical devices is common, despite the lack of laws. There are no official laws regarding reprocessing of single-use medical devices in countries like South Korea, India and Japan.

The single-use medical device reprocessing market is in its infancy and few players dominate the market.

The major players operating in the global single-use medical device reprocessing market include SterilMed Inc., Centurion Medical Products Corporation, Stryker Corporation, Hygia Health Services Inc, Medline ReNewal, Vanguard AG, Midwest Reprocessing Center and others. These companies have successfully proven the economic and environmental benefits of reprocessing single-use medical devices. As the regulatory scenario in the Asia-Pacific region and Europe unfolds, these companies will gain significantly.

Get a sample report with the latest Covid19 @ scan

Reasons to buy this report

• Current and future outlook for the global single-use medical device reprocessing market in developed and emerging markets.
• The segment which is expected to dominate the market as well as the segment which holds the highest CAGR during the forecast period.
• Regions / countries expected to experience the fastest growth rates during the forecast period
• The latest developments, market shares and strategies used by the main market players

Access research reports designed especially for you and your organization to explore practical growth strategies and recommendations


Chapter 1 Industry overview
1.1 Definition
1.2 Assumptions
1.3 Scope of the research
1.4 Market Analysis by Regions
1.5 Analysis of Single-Use Medical Device Reprocessing Market Size from 2021 to 2028
11.6 COVID-19 outbreak: impact on the single-use medical device reprocessing industry

Chapter 2 Global Single Use Medical Device Reprocessing Competition by Types, Applications and Major Regions and Countries
2.1 Global reprocessing of single-use medical devices (volume and value) by type
2.3 Global Single-Use Medical Device Reprocessing (Volume & Value) by Regions

chapter 3 Production market analysis
3.1 Global Production Market Analysis
3.2 Regional production market analysis

Chapter 4 Global Single Use Medical Device Reprocessing Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Single Use Medical Device Reprocessing Market Analysis
Chapter 6 Analysis of the single-use medical device reprocessing market in East Asia
Chapter 7 Single-use medical device reprocessing market analysis in Europe
Chapter 8 Single-use medical device reprocessing market analysis in South Asia
Chapter 9 Single-use medical device reprocessing market analysis in Southeast Asia
Chapter 10 Middle East Single Use Medical Device Reprocessing Market Analysis
Chapter 11 Single-use medical device reprocessing market analysis in Africa
Chapter 12 Single-use medical device reprocessing market analysis in Oceania
Chapter 13 South America Single Use Medical Device Reprocessing Market Analysis
Chapter 14 Company profiles and key figures for the reprocessing of single-use medical devices
Chapter 15 Global Single Use Medical Device Reprocessing Market Forecast (2021-2027)
Chapter 16 Conclusion
Research methodology

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, custom research reports, and advisory services. We are known for our actionable insights and authentic reports in a variety of fields including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually every field. and a comprehensive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reporting. We are also committed to playing a leading role in providing insight into various post-COVID-19 sectors and continue to deliver measurable and sustainable results to our clients.


Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837

Source link

Does the use of electronic devices affect mental traits? Wed, 08 Dec 2021 08:56:01 +0000

Credit: CC0 Public Domain

In a study published in Biology of drug addiction, investigators found significant associations between the use of electronic devices and signs of depression and anxiety, as well as smoking and alcohol consumption. The team also found some genetic variants linked to these traits.

The study included data on thousands of individuals from UK Biobank. Three indicators of electronic device use were included in the study: watching television, using the computer and playing on the computer.

According to the authors, the study results suggest that reducing the time spent using electronic devices may help reduce mental health burdens.

Using DNA Sequencing Data with Electronic Health Records to Find Rare Variants Behind Inherited Diseases

More information:
Jing Ye et al, Associations between electronic devices use and common mental traits: A gene-environment interaction model using the UK Biobank data, Biology of drug addiction (2021). DOI: 10.1111 / adb.13111

Quote: Does the use of electronic devices affect mental traits? (2021, December 8) retrieved December 8, 2021 from

This document is subject to copyright. Other than fair use for private study or research purposes, no part may be reproduced without written permission. The content is provided for information only.

Source link

AMRA Medical’s MRI Muscle Assessment Technology Approved for Clinical Use in Canada Thu, 02 Dec 2021 12:53:00 +0000

AMRA® MAsS Scan is offered as one of the medical device services of AMRA where AMRA® The protocol uses rapid magnetic resonance imaging (MRI) from the neck to the knee to produce a patient-specific report. The report contains the MAsS, anatomical and color-coded images, as well as precise body composition measurements with contextual information based on AMRA’s benchmark database.

Now, with the help of an objective, actionable and easy-to-understand MAsS, clinicians in Canada can accurately assess the muscles before and after organ transplantation to better understand the patient’s health. For example, clinicians can more accurately predict, diagnose, and monitor sarcopenia; or they can track a patient’s muscle health by detecting large and small changes in muscle and fatness.

Eric Converse, CEO of AMRA, said: “We are very excited to bring this technology to Canada. AMRA® The MAsS Scan will greatly benefit patients by enabling clinicians to assess sarcopenia, take action, and improve patient outcomes. The Muscle Assessment Score is simple to use and understand, and it establishes a common language among physicians for sarcopenia. an MRI already prescribed. “

Learn more about AMRA® Mass scan enabled AMRA website.

About AMRA Medical
AMRA is a digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition analysis, the ability to automatically produce multiple fat and muscle biomarkers with unmatched precision and accuracy, as well as contextual disease information, all at from a single rapid MRI of the whole body.


Source link

Startups use technology, “gamification” for public health issues Tue, 30 Nov 2021 12:02:22 +0000

Wellth, founded in 2014, seeks the answers using behavioral economics, which takes into account individual biases and how they affect decision making. Users can earn small payments, funded by Wellth clients which include medical groups and insurance companies, for things like taking their medications daily, a “gamified” feature that encourages addictive behaviors.

Sequences can save attendees more money – which can only be spent on things like groceries, household needs, home repairs, and auto costs – and users can spin a ‘prize wheel. Every few days for a chance to win bigger winnings. Gamification is frequently used by fintech and other tech companies to disrupt traditional business models and capture market share.

Wellth has raised more than $ 11 million in recent years, has tens of thousands of users, and has reduced hospitalization rates by up to 40% in some populations, Loper said.

So-called digital health companies are attracting more and more capital, according to Megan Zweig, chief operating officer of the Rock Health seed fund. In the first nine months of 2021, these companies made more than $ 20 billion in venture capital investments, up from $ 14.6 billion in 2020 and $ 7.9 billion in 2019, the company said. .

It remains to be seen whether digital health will lead to better health outcomes, Zweig said, but the industry is already changing the way people think about healthcare.

Source link

Can pregnant women use marijuana? Here’s why drug use increases during pregnancy Sun, 28 Nov 2021 05:00:00 +0000

Legal sales of cannabis, first for medical purposes and now for recreational purposes, have spread across the country. Yet despite what appear to be years of public messages about the idea that marijuana is a fundamentally harmless drug that we needlessly penalize people for using and selling, many Americans still seem uncomfortable with it. encourage its use. And they might be right.

Currently, cities in New York state have until the end of the year to decide whether they wish to allow cannabis dispensaries to operate within their borders. They have every incentive to say yes, including potential millions of dollars in sales tax revenue, but many are revisiting an old slogan: just say no. In New Jersey, according to a analysis of the Rockefeller Institute, three-quarters of “municipalities withdrew from the six categories of adult marijuana licenses (grower, manufacturer, wholesaler, distributor, retailer and delivery) that were described in state law. “

You don’t have to look far to find out why. Take the case of pregnant women: A study published this fall found that children of mothers who use marijuana during or soon after pregnancy are twice as likely as other children to become anxious, aggressive or hyperactive. The National Academy of Sciences Proceedings article describes how researchers looked at the presence of a chemical in the placenta, as well as hair hormone levels in young children, and then measured the performance of these children on a standardized behavioral assessment as well as their heart rate variability.

These are no small results, and they are even more concerning considering that many pregnant women seek marijuana to relieve symptoms of pregnancy, such as nausea. Women “tend to think that smoking and drinking during pregnancy should be avoided at all costs, but cannabis not,” Yoko Nomura, behavioral neuroscientist at City University of New York and co-author of the study, told the New York Times. “We have a long way to go in educating pregnant women, policy makers and even OB-GYN doctors on this issue.”

But where did they get the impression that cannabis is much less dangerous for their health than drinking and smoking? Would it be all government officials? from New Jersey Governor Phil Murphy recently called it was a “world class industry”, and its only concern was that the issue of “fairness” be addressed, meaning that people of all races could share in the profits.

A Kaiser Permanente study in California earlier this year, rates of cannabis use among women in early pregnancy had increased by 25% by the start of the pandemic. While overall state usage has increased over the same time period – around 8% for women – it looks like pregnant women are really benefiting. “Pregnant women are more likely to use cannabis if they are depressed, anxious, or have experienced trauma,” said lead author Kelly Young-Wolff. “It is very possible that more pregnant women will use cannabis in an attempt to cure these problems on their own during the pandemic. ”

Obtaining cannabis for medical purposes has of course been much easier in recent years. While the authors don’t outright blame the legalization, they do note that the results are consistent with the increase in overall cannabis sales in California. According to an article from the Center for Infectious Disease Research and Policy, “State data shows that quarterly average taxable cannabis sales from April to December 2020 were $ 1.2 billion, while the quarterly average for the previous 15 months was $ 712 million, a 68.5% increase. “

But the laws of supply and demand are not the only causes of this problem. It is also the attitude we adopt towards pregnant women when it comes to drugs. Although the public has become widely aware of the problems of babies born exposed to substances – the terrible withdrawal symptoms that plague them during their first few weeks outside the womb – there is also a competing narrative that women who use drugs during pregnancy are victims. and cannot be held responsible for its actions.

Some activists believe that drug use during pregnancy should not be monitored at all. A group called upEnd, which advocates for the abolition of the foster care system because of its racially disparate impact, argues that we should end drug testing of new mothers and infants because it excessively involves and unnecessarily black women in the child welfare system.

Last year, New York City ended drug testing of mothers without their written consent. Lisa Sangoi, co-director and co-founder of the Family Power Movement, noted drug testing “targets black and brown communities for policing, surveillance and control so that white and wealthy people who also use drugs at the same rate are rarely, if ever, monitored.”

Of course, the real solution may be to simply test everyone. And given how much more drug use during pregnancy has become, how much women are now looking for cannabis as a medical intervention, and how much we now realize that it is dangerous for babies, this idea is more. that logical.

Naomi Schaefer Riley is a resident researcher at the American Enterprise Institute, a contributor to Deseret News and author of “No way to treat a child: How the foster care system, family courts and racial activists are destroying young lives. “

Source link

New Poll Shows Majority of Massachusetts People Think Cannabis Legalization Is Overall Positive for the State Fri, 26 Nov 2021 12:52:00 +0000

A poll released this week showed that only a fraction of Massachusetts residents believe the legalization of marijuana has had a negative impact on the state.

University of Massachusetts Amherst and WCVB published a poll Monday in which 61% of those polled said legal cannabis for adult use was overall positive for the state. While 25% said it was neither positive nor negative, only 13% said it was negative.

“This poll also shows that legalization reduces the stigma historically associated with cannabis, which will only allow the Commission to continue to make progress in its efforts to ensure full participation in this industry by disproportionately affected communities,” he said. said the chairman of the Cannabis Control Commission, Steven J. Hoffman. in a report. “Our work is far from over, and my colleagues and I will continue to speak out on the solutions needed to ensure Massachusetts lives up to its equity mandate.”

The survey was conducted November 9-16 and included 750 respondents.

On November 8, 2016, voters in Massachusetts approved the legalization, regulation and taxation of cannabis with 1,769,328 voters, or 52%, in favor of Question 4, and 1,528,219 voters, or 45%, in the ‘opposition. Legalization came following the approval of cannabis for medical purposes in 2012 and the decriminalization of small amounts of the plant in 2008.

November 20 marked the third anniversary of the opening of the first adult marijuana retailers in Massachusetts, the first on the East Coast.

Since then, 179 stores have started their activities. A total of 325 adult-use marijuana establishments, including indoor and outdoor growers, product manufacturers, micro-businesses, delivery companies and independent testing labs, have opened, according to the Commission of cannabis control.

The adult use industry generated more than $ 2.3 billion in gross sales during this period, CCC said.

Associated content:

Source link

Medical Device News: Latest medical device news, Indian medical device news and updates Wed, 24 Nov 2021 11:46:00 +0000

There is smog in the air and it will continue for about a month. It has triggered serious health problems for all age groups, especially children and the elderly.

Extreme cases may also require a ventilator.

Air pollution is at the root of the global burden of respiratory and allergic diseases, including asthma, chronic obstructive pulmonary disease, pneumonia and possibly tuberculosis. A few recent epidemiological studies have made it possible to recognize the emerging importance of air pollution linked to traffic in both developed and less developed countries. In addition, continued emissions from household fires burning biomass fuels mainly in the less developed world can lead to poor respiratory conditions. because patients with respiratory problems are more likely to suffer due to increasing levels of air pollution. Some extreme cases can lead to the use of ventilators for treatment. The pandemic has already caused many respiratory problems making organs weak. So it is an alarming situation to take good care of often neglected organs in the human body like the respiratory organs. In an exclusive conversation with Financial Express Online, Ashok Patel, CEO and Founder, Max Ventilator spoke about the impact of pollution on respiratory diseases, use and increase in demand for ventilators due to severe pollution. Extracts:

How is the increase in post-Diwali pollution impacting the respiratory organs?

The increase in pollution after Diwali has made the air quality in Delhi “serious”. There is smog in the air and it will continue for about a month. It has triggered serious health problems for all age groups, especially children and the elderly. This causes irreparable and irreversible damage. People suffer from respiratory allergies, respiratory problems, asthma and bronchitis due to the increased level of pollution.

Why can poor respiratory care lead to increased ventilator use?

There are a whole host of conditions a person can face if their respiratory organs are not taken care of regularly: from respiratory allergies to asthma to infections leading to pneumonia and bronchitis to extremely severe conditions. such as lung cancer and COPD and acute respiratory failure, the list is quite long and many of them would require immediate care and mechanical ventilation.

We often tend to take most of our respiratory organs for granted as long as they are functioning on the outside without realizing that even the slightest problem with any of the organs, if not treated in time, could deteriorate. into a life-long debilitating disease requiring prolonged or even lifelong progress. level of medical care, including ventilatory support.

How can ventilators help with poor breathing conditions?

It helps us breathe when you are sick, injured, sedated for an operation, or have severe breathing problems. It pumps oxygen-rich air into your lungs. It also helps us breathe out carbon dioxide, a harmful waste gas that our bodies need to get rid of.

What types of ventilators are suitable for treating respiratory problems?

Although there is a range of modern era ventilators today, from intensive care ventilators to intensive care ventilators, from home care anesthesia ventilators, and from portable ventilators to related devices such as HFOT to help. people with their breathing and related problems, people should regularly take care of their breathing problems. systems and organs in a way that excludes or minimizes the need for ventilatory support.

fans, covid, air pollution, smogAshok Patel, CEO and Founder, Max Ventilator

Max Ventilator recently launched a High Flow Oxygen Therapy Machine (HFOT) that not only offers nearly 100% chance of survival, but also results in lower operating costs than a traditional ventilator. A modern, state-of-the-art device, HFOT equipment promises to add strength and strength to the ongoing battle against a resurgent Covid-19 virus. Another is the WeanX ventilator which promises to be an all-weather ventilation solution for hospitals, healthcare facilities and patients.

When is the ventilator prescribed for a patient?

Here are some of the health concerns when the ventilator is prescribed to a patient:

During and after surgery

When breathing alone is very difficult

Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gerhig’s disease

Coma or loss of consciousness

· cerebral lesion – brain-damage

Pulmonary collapse

Chronic obstructive pulmonary disease (COPD)

Drug overdose

Guillain Barre syndrome

· Pulmonary infection

Myasthenia gravis



Premature lung development (in babies)


Damage to the upper spinal cord

· Ventilators were also used on some patients diagnosed with COVID-19 during the 2020 pandemic. This is only for the most severe cases.

Is there an increase in demand for fans due to the high pollution?

Yes, there is an increase in demand for ventilators. After facing the covid experience, hospitals prepare upstream for any unforeseen situation. So that in times of crisis, they are ready to deal with it without facing the shortage of medical devices for treatment. Due to poor air quality and severe pollution, there are risks of increased respiratory problems. Extreme cases may also require a ventilator.

Get live stock quotes for BSE, NSE, US market and latest net asset value, mutual fund portfolio, see the latest IPO news, top IPOs, calculate your tax with the help of the income tax calculator, know the best winners, the best losers and the best equity funds in the market. Like us on Facebook and follow us on Twitter.

Source link